English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSun pharma advanced research company

    Sun Pharma Advanced Research Company

    Jump to
    • Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y

      Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y

    • Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y

      Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y

    • Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y

      Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y

    • Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y

      Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y

    • Sun Pharma Adv Standalone December 2024 Net Sales at Rs 14.91 crore, up 7.58% Y-o-Y

      Sun Pharma Adv Standalone December 2024 Net Sales at Rs 14.91 crore, up 7.58% Y-o-Y

    • Sun Pharma Adv Consolidated September 2024 Net Sales at Rs 12.86 crore, down 39.28% Y-o-Y

      Sun Pharma Adv Consolidated September 2024 Net Sales at Rs 12.86 crore, down 39.28% Y-o-Y

    • Sun Pharma Adv Standalone September 2024 Net Sales at Rs 12.86 crore, down 39.28% Y-o-Y

      Sun Pharma Adv Standalone September 2024 Net Sales at Rs 12.86 crore, down 39.28% Y-o-Y

    • Sun Pharma Adv Consolidated June 2024 Net Sales at Rs 16.81 crore, down 29.81% Y-o-Y

      Sun Pharma Adv Consolidated June 2024 Net Sales at Rs 16.81 crore, down 29.81% Y-o-Y

    • Sun Pharma Adv Standalone June 2024 Net Sales at Rs 16.81 crore, down 29.81% Y-o-Y

      Sun Pharma Adv Standalone June 2024 Net Sales at Rs 16.81 crore, down 29.81% Y-o-Y

    • Stock Radar: ICICI Bank, India Cements, BHEL, Biocon, REC, IndusInd Bank, UltraTech in focus on Monday

      Stock Radar: ICICI Bank, India Cements, BHEL, Biocon, REC, IndusInd Bank, UltraTech in focus on Monday

      UltraTech Cement, Maruti Suzuki India, Sun Pharma Advanced Research Company, Glenmark Life Sciences, Hindustan Zinc, Godawari Power and Ispat, Manappuram Finance, Jubilant Pharmova, and Strides Pharma Science will also be in focus on Monday.

    • Sun Pharma Adv Standalone March 2024 Net Sales at Rs 16.56 crore, down 65.28% Y-o-Y

      Sun Pharma Adv Standalone March 2024 Net Sales at Rs 16.56 crore, down 65.28% Y-o-Y

    • Sun Pharma Advanced slips 5% on halting Parkinson's drug trial

      Sun Pharma Advanced slips 5% on halting Parkinson's drug trial

      The Sun Pharma Advanced Research Company stock has gained 40 percent this year against a 4 percent rise in the benchmark Nifty50

    • Sun Pharma Adv Standalone December 2023 Net Sales at Rs 13.86 crore, down 89.43% Y-o-Y

      Sun Pharma Adv Standalone December 2023 Net Sales at Rs 13.86 crore, down 89.43% Y-o-Y

    • Experts bet on these 10 stocks as raging bulls of D-St keep Nifty charged up

      Experts bet on these 10 stocks as raging bulls of D-St keep Nifty charged up

      The experts further advised to continue with the buy-on-dips strategy till the index holds 19,600-19,500 on the downside

    • Sun Pharma Adv Standalone September 2023 Net Sales at Rs 21.18 crore, down 32.85% Y-o-Y

      Sun Pharma Adv Standalone September 2023 Net Sales at Rs 21.18 crore, down 32.85% Y-o-Y

    • Trade Spotlight | Your strategy for Sterlite Technologies, BSE, Sun Pharma Advanced Research today

      Trade Spotlight | Your strategy for Sterlite Technologies, BSE, Sun Pharma Advanced Research today

      The BSE stock has seen a breakout of falling resistance trendline adjoining March 15 last year (record high) and August 24 this year. The stock climbed over 6 percent to Rs 967.8 and formed long bullish candlestick pattern on the daily timeframe with above average volumes.

    • Sun Pharma Adv Standalone June 2023 Net Sales at Rs 23.95 crore, down 15.85% Y-o-Y

      Sun Pharma Adv Standalone June 2023 Net Sales at Rs 23.95 crore, down 15.85% Y-o-Y

    • Sun Pharma Adv Standalone March 2023 Net Sales at Rs 47.69 crore, up 88.95% Y-o-Y

      Sun Pharma Adv Standalone March 2023 Net Sales at Rs 47.69 crore, up 88.95% Y-o-Y

    • Sun Pharma Advanced Research Company falls 5% as quarterly loss widens to Rs 82 crore

      Sun Pharma Advanced Research Company falls 5% as quarterly loss widens to Rs 82 crore

      There has been a significant increase in clinical trial expenses, product development expenses, and professional charges during the last quarter of financial year 2022-23.

    • Sun Pharma Adv Standalone December 2022 Net Sales at Rs 131.09 crore, up 110.93% Y-o-Y

      Sun Pharma Adv Standalone December 2022 Net Sales at Rs 131.09 crore, up 110.93% Y-o-Y

    • Sun Pharma Adv Standalone September 2022 Net Sales at Rs 31.54 crore, up 13.17% Y-o-Y

      Sun Pharma Adv Standalone September 2022 Net Sales at Rs 31.54 crore, up 13.17% Y-o-Y

    • Top 10 trading ideas for November series as bulls gear up to charge again

      Top 10 trading ideas for November series as bulls gear up to charge again

      The paper stocks were buzzing last week as we witnessed buying interest in some of the counters with good volumes. Satia Industries has seen a breakout from a long consolidation phase and has resumed its uptrend with a ‘Higher Top Higher Bottom’ structure

    • Hot Stocks | Here's why you should bet on Sun Pharma Advanced Research, Jubilant Pharmova for short term

      Hot Stocks | Here's why you should bet on Sun Pharma Advanced Research, Jubilant Pharmova for short term

      SPARC has witnessed a consolidation breakout on the back of robust volumes and surged above all its major EMAs (exponential moving averages) on the daily time frame. Simultaneously, in the last couple of sessions, strong traction has been seen in the overall sector.

    • Sun Pharma Adv Standalone June 2022 Net Sales at Rs 28.46 crore, up 29.42% Y-o-Y

      Sun Pharma Adv Standalone June 2022 Net Sales at Rs 28.46 crore, up 29.42% Y-o-Y

    • Sun Pharma Adv Standalone December 2021 Net Sales at Rs 62.15 crore, up 184.96% Y-o-Y

      Sun Pharma Adv Standalone December 2021 Net Sales at Rs 62.15 crore, up 184.96% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347